Enhanc3D Genomics raises £10m in Series A financing
Cambridge-based Enhanc3D Genomics Ltd has raised £10m in Series A financing led by BGF and Parkwalk Advisors.
Univercells SA raises 44m in first close of its Series D
Belgian CDMO Univercells SA has raised 44m through the first close of its Series D financing round led by Belgian and international investors. I
Adrenomed set to start pivotal trial in sepsis
German Adrenomed AG has got a recommendation from the EMA to push its Adrenomedullin-binding antibody Adrecizumab into a pivotal Phase III study.
Mablink raises $31m in Series A financing
Mablink Bioscience has baged 31m in a Series A round led by Sofinnova Partners and Mérieux Equity Partners to speed up its pipeline of ADCs.
Experts showcase next-gen biotech solutions to climate crisis
Industry experts have presented the latest biotech solutions for tackling climate change at the first INDUSTRIA BIOTEC conference, Europe’s new forum for the industrial biotech sector.
Stalicla SA and Evgen Pharma plc ink $160.5m licensing deal for SFX-01
Precision neuroscience company Stalicla SA has licensed SFX-01 from Evgen Pharma plc in neurodevelopmental disorders and schizophrenia.
Clinical Microbiomics A/S bags 10m financing
Danish microbiome specialist Clinical Microbiomics A/S has completed a 10m growth financing led by Seventure Partners.
EU starts largest study on factors affecting mental health
The EU Commission has granted £8.4m for Youth-GEMS, the largest ever study to identify genetic and other risks affecting mental health in adolescence.
Standing Ovation wins Industria Biotecs start-up pitch
French Standing Ovation has won the start-up pitch of Industria Biotec, held for the first time in Berlin. The event presents biotechnological solutions to save the climate.
Araris Biotech closes $24m Series A financing round
Swiss ADC maker Araris Biotech AG has added a $24m financing round to its CHF15.2m (S17.8m) seed round in 2020 to expand its portfolio of proprietary antibody drug conjugates.